Format

Send to

Choose Destination
J Invest Dermatol. 2015 May;135(5):1275-1282. doi: 10.1038/jid.2014.456. Epub 2014 Oct 27.

The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.

Author information

1
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: r.e.genders@lumc.nl.
2
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
3
Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
4
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
5
Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
6
Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
7
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
8
Department of Biostatistics, Leiden University Medical Center, Leiden, The Netherlands.

Abstract

Organ transplant recipients (OTRs) have an increased risk of developing keratinocyte carcinomas (KCs). The aim of this study was to correlate infection with human papillomaviruses (HPVs) belonging to the beta genus (Beta-papillomavirus (Beta-PV)) at transplantation with later development of KCs. In a cohort study, sera collected between 1 year before and 1 year after transplantation of OTRs transplanted between 1990 and 2006 were tested for antibody responses against the L1 capsid antigen of Beta-PV and other HPV genera (Gamma-, Mu-, Nu-, and Alpha-PV) using multiplex serology. The OTRs were followed for a maximum of 22 years. Cox regression models with KC, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) as outcome variables were used. Out of 445 OTRs, 60 had developed KC: 14 developed only SCC, 24 only BCC, and 22 both types of KC. The time-dependent hazard ratio (HR) to develop either or both types of KC, adjusted for age, sex, and transplanted organ, in tested Beta-PV-seropositive OTR around the time of transplantation compared with Beta-PV-seronegative OTR was 2.9 (95% confidence interval (CI) 1.3-6.4). The HR for SCC was 2.9 (95% CI 0.99-8.5) and for BCC it was 3.1 (95% CI 1.2-8.0). There was also an association between Mu-PV seropositivity and KC, but there were no significant associations between other HPV genera tested and KC. A positive seroresponse for Beta-PV around transplantation significantly predicted the development of KC in OTRs up to 22 years later, providing additional evidence that infection with Beta-PV has a role in KC carcinogenesis.

PMID:
25347116
DOI:
10.1038/jid.2014.456
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center